| 1 |
高悦益. TRP通道蛋白MCOLN1对急性髓系白血病的影响及机制研究[D]. 重庆:重庆医科大学, 2024.
|
| 2] |
何苗, 田红娟, 毛东锋, 等. 急性髓系白血病患者基因突变特征及预后生存分析[J]. 中国实验血液学杂志, 2025, 33(3):691-697.
|
| 3 |
李哲, 李斌. 实体瘤迭合白血病12例分析[J]. 现代预防医学, 2013, 40(3):600-601.
|
| 4 |
Chung KY, Morrone G, Schuringa JJ, et al. Enforced expression of NUP98-HOXA9 in human CD34(+) cells enhances stem cell proliferation[J]. Cancer Res, 2006, 66(24):11781-11791.
|
| 5 |
张朕豪, 万伟, 李玲娣, 等. 伴t(7;11)(p15;p15)/NUP98-HOXA9急性髓系白血病3例报告并文献复习[J]. 中华血液学杂志, 2022, 43(2):150-153.
|
| 6 |
张梦利. RNA结合蛋白RBM5通过直接激活癌基因HOXA9促进急性髓系白血病发展[D]. 江苏:苏州大学, 2024.
|
| 7 |
Fang Y, Han XF, Shen LJ, et al. NUP98-HOXA9 bearing acute myeloid leukemia[J]. Blood, 2022, 140(S1): 11614.
|
| 8 |
Chou WC, Chen CY, Hou HA, et al. Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients[J]. Leukemia, 2009, 23(7):1303-1310.
|
| 9 |
Kroon E, Thorsteinsdottir U, Mayotte N, et al. NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice[J]. EMBO J, 2001, 20(3):350-361.
|
| 10 |
Takeda A, Goolsby C, Yaseen NR. NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells[J]. Cancer Res, 2006, 66(13):6628-6637.
|
| 11 |
Deveau AP, Forrester AM, Coombs AJ, et al. Epigenetic therapy restores normal hematopoiesis in a zebrafish model of NUP98-HOXA9-induced myeloid disease[J]. Leukemia, 2015, 29(10):2086-2097.
|
| 12 |
Gough SM, Slape CI, Aplan PD. NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights[J]. Blood, 2011, 118(24):6247-6257.
|
| 13 |
Takeda A, YaseenNR. Nucleoporins and nucleocytoplasmic transport in hematologic malignancies[J]. Semin Cancer Biol, 2014, 27:3-10.
|
| 14 |
Yassin ER, Sarma NJ, Abdul-Nabi AM, et al. Dissection of the transformation of primary human hematopoietic cells by the oncogene NUP98-HOXA9[J]. PLoS One, 2009, 4(8):e6719.
|
| 15 |
Wei S, Wang S, Qiu S, et al. Clinical and laboratory studies of 17 patients with acute myeloid leukemia harboring t(7;11)(p15;p15) translocation[J]. Leuk Res, 2013, 37(9):1010-1015.
|
| 16 |
Hollink IH, van den Heuvel-Eibrink MM, Arentsen-Peters ST, et al. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern[J]. Blood, 2011, 118(13):3645-3656.
|
| 17 |
de Rooij JD, Hollink IH, Arentsen-Peters ST, et al. NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern[J]. Leukemia, 2013, 27(12):2280-2288.
|
| 18 |
Ho H, Skaist AM, Pallavajjala A, et al. NUP98-PHF23 fusion is recurrent in acute myeloid leukemia and shares gene expression signature of leukemic stem cells[J]. Leuk Res, 2016, 45:1-7.
|
| 19 |
Eguchi-Ishimae M, Eguchi M, Ohyashiki K, et al. Enhanced expression of the EVI1 gene in NUP98/HOXA-expressing leukemia cells[J]. Int J Hematol, 2009, 89(2):253-256.
|
| 20 |
Burillo-Sanz S, Morales-Camacho RM, Caballero-Velázquez T, et al. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression[J]. Int J Lab Hematol, 2016, 38(1):64-71.
|